[go: up one dir, main page]

IL145288A0 - Novel cytokin zalpha11 ligand - Google Patents

Novel cytokin zalpha11 ligand

Info

Publication number
IL145288A0
IL145288A0 IL14528800A IL14528800A IL145288A0 IL 145288 A0 IL145288 A0 IL 145288A0 IL 14528800 A IL14528800 A IL 14528800A IL 14528800 A IL14528800 A IL 14528800A IL 145288 A0 IL145288 A0 IL 145288A0
Authority
IL
Israel
Prior art keywords
cytokin
novel
polypeptide
zalpha11 ligand
seq
Prior art date
Application number
IL14528800A
Other languages
English (en)
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27385745&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL145288(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of IL145288A0 publication Critical patent/IL145288A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL14528800A 1999-03-09 2000-03-09 Novel cytokin zalpha11 ligand IL145288A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US26490899A 1999-03-09 1999-03-09
US26599299A 1999-03-11 1999-03-11
US14201399P 1999-07-01 1999-07-01
PCT/US2000/006067 WO2000053761A2 (en) 1999-03-09 2000-03-09 Human cytokine as ligand of the zalpha receptor and uses thereof

Publications (1)

Publication Number Publication Date
IL145288A0 true IL145288A0 (en) 2002-06-30

Family

ID=27385745

Family Applications (5)

Application Number Title Priority Date Filing Date
IL14528800A IL145288A0 (en) 1999-03-09 2000-03-09 Novel cytokin zalpha11 ligand
IL145288A IL145288A (en) 1999-03-09 2001-09-05 Isolated cytokine zalpha11 ligand polypeptide and uses thereof
IL195713A IL195713A (en) 1999-03-09 2008-12-04 A new antibody to the cytokine 11 ligand ZALPHA and the method for its preparation
IL207403A IL207403A (en) 1999-03-09 2010-08-04 Antibody to cytokine 11ZALPHA ligand, a method for its preparation and a method for detecting the presence of ZALPHA11 ligand
IL207424A IL207424A (en) 1999-03-09 2010-08-05 Use of 11zalpha ligand antagonist preparations, 11zalpha ligand antagonist preparations, antagonist production method and antagonist produced using the method

Family Applications After (4)

Application Number Title Priority Date Filing Date
IL145288A IL145288A (en) 1999-03-09 2001-09-05 Isolated cytokine zalpha11 ligand polypeptide and uses thereof
IL195713A IL195713A (en) 1999-03-09 2008-12-04 A new antibody to the cytokine 11 ligand ZALPHA and the method for its preparation
IL207403A IL207403A (en) 1999-03-09 2010-08-04 Antibody to cytokine 11ZALPHA ligand, a method for its preparation and a method for detecting the presence of ZALPHA11 ligand
IL207424A IL207424A (en) 1999-03-09 2010-08-05 Use of 11zalpha ligand antagonist preparations, 11zalpha ligand antagonist preparations, antagonist production method and antagonist produced using the method

Country Status (23)

Country Link
EP (3) EP2295577A3 (de)
JP (1) JP4405686B2 (de)
KR (1) KR100743640B1 (de)
CN (5) CN1827639A (de)
AT (1) ATE377076T1 (de)
AU (2) AU777842B2 (de)
BR (1) BR0008772B1 (de)
CA (1) CA2366921C (de)
CZ (1) CZ302921B6 (de)
DE (1) DE60036930T2 (de)
DK (1) DK1165791T3 (de)
ES (1) ES2295019T3 (de)
HU (1) HU229148B1 (de)
IL (5) IL145288A0 (de)
MX (1) MXPA01009074A (de)
NO (2) NO331551B1 (de)
NZ (1) NZ514708A (de)
PL (1) PL207350B1 (de)
PT (1) PT1165791E (de)
RU (1) RU2346951C2 (de)
UA (1) UA84387C2 (de)
WO (1) WO2000053761A2 (de)
ZA (1) ZA017370B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7198789B2 (en) 1998-03-17 2007-04-03 Genetics Institute, Llc Methods and compositions for modulating interleukin-21 receptor activity
US6057128A (en) 1998-03-17 2000-05-02 Genetics Institute, Inc. MU-1, member of the cytokine receptor family
US7189400B2 (en) 1998-03-17 2007-03-13 Genetics Institute, Llc Methods of treatment with antagonists of MU-1
MXPA01009074A (es) * 1999-03-09 2002-03-27 Zymogenetics Inc Nuevo ligando zalfa11 de citocina.
WO2003028630A2 (en) 2001-10-04 2003-04-10 Genetics Institute Llc. Methods and compositions for modulating interleukin-21 receptor activity
AU2002336676A1 (en) 2001-11-05 2003-05-19 Zymogenetics, Inc Il-21 antagonists
AU2003243415A1 (en) * 2002-06-07 2003-12-22 Zymogenetics, Inc. Use of il-21 in cancer and other therapeutic applications
MXPA05000655A (es) 2002-07-15 2006-02-22 Harvard College Metodos y composiciones para modular el desarrollo y la funcion de las celulas t helper (th).
CA2501807A1 (en) * 2002-10-11 2004-04-22 Novo Nordisk A/S Treatment of allergic conditions by use of il 21
RU2005113992A (ru) * 2002-10-11 2005-10-27 Ново Нордиск А/С (DK) Лечение аллергических состояний с использованием il-21
RU2354703C2 (ru) * 2002-12-13 2009-05-10 Займодженетикс, Инк. Продуцирование il-21 в прокариотических клетках-хозяевах
RU2005131852A (ru) 2003-03-14 2006-04-20 Уайт (Us) Антитела против человеческого рецептора il-21 и их применение
US20050124044A1 (en) * 2003-06-19 2005-06-09 Cunningham Mark R. Interleukin-21 analogs
DE602004031341D1 (de) 2003-07-21 2011-03-24 Transgene Sa Multifunktionelle cytokine
DE602004031681D1 (de) 2003-07-21 2011-04-14 Transgene Sa Multifunktionelle Cytokine
CA2538083A1 (en) * 2003-09-25 2005-04-07 Zymogenetics, Inc. Methods of treating autoimmune diseases using il-21
US20060228331A1 (en) * 2003-10-10 2006-10-12 Novo Nordisk A/S IL-21 Derivatives and variants
CN102516386A (zh) * 2003-10-10 2012-06-27 诺沃挪第克公司 Il-21衍生物
ES2428358T3 (es) 2003-10-17 2013-11-07 Novo Nordisk A/S Terapia de combinación
EP1708737A2 (de) * 2004-01-15 2006-10-11 Novo Nordisk A/S Verwendung von interleukin-21 zur behandlung von autoimmunkrankheiten und allograft-abstossung
EP2033662B1 (de) 2004-01-21 2012-10-17 Novo Nordisk Health Care AG Transglutaminase vermittelte konjugation von peptiden.
GT200600148A (es) 2005-04-14 2006-11-22 Metodos para el tratamiento y la prevencion de fibrosis
RU2412199C2 (ru) 2005-04-18 2011-02-20 Ново Нордиск А/С Варианты ил-21
PL1963369T3 (pl) * 2005-11-28 2013-10-31 Zymogenetics Inc Antagoniści IL-21
CA2666426A1 (en) 2006-10-26 2008-05-02 Novo Nordisk A/S Il-21 variants
EP2109620B1 (de) 2006-12-21 2012-08-22 Novo Nordisk A/S Interleukin-21-varianten mit geänderter bindung an den il-21-rezeptor
EP3103813A1 (de) 2007-12-07 2016-12-14 ZymoGenetics, Inc. Anti-humane il-21 monoklonale antikörper
AR071885A1 (es) 2008-05-23 2010-07-21 Wyeth Corp Proteinas de union al receptor de interleuquina 21
JP2011520989A (ja) 2008-05-23 2011-07-21 ワイス・エルエルシー インターロイキン−２１受容体の結合性タンパク質を利用する治療法
CA2739357A1 (en) 2008-09-23 2010-04-08 Wyeth Llc Methods for predicting production of activating signals by cross-linked binding proteins
CN102021196B (zh) * 2009-11-20 2013-06-26 上海杰隆生物工程股份有限公司 毕赤酵母生产重组人白细胞介素21的方法
CA2877933A1 (en) 2012-06-27 2014-01-03 Yuri Bushkin Rapid assays for t-cell activation by rna measurements using flow cytometry
WO2015110930A1 (en) 2014-01-24 2015-07-30 Pfizer Inc. Modified interleukin 21 receptor proteins
EP2982693A1 (de) * 2014-08-07 2016-02-10 Affimed Therapeutics AG CD3 Bindungsdomäne
EP4149539A4 (de) * 2020-05-14 2024-06-12 Metaclipse Therapeutics Corporation Zusammensetzungen und verfahren zum nachweis und zur behandlung einer sars-cov-2-infektion
US12012441B2 (en) 2020-10-26 2024-06-18 Neptune Biosciences Llc Engineered human IL-21 cytokines and methods for using the same
CN112662694A (zh) * 2020-12-25 2021-04-16 康九生物科技(长春)有限公司 一种麦芽糖结合蛋白、麦芽糖结合蛋白表达载体、重组工程菌及其应用
US20250000946A1 (en) * 2021-09-26 2025-01-02 WuXi Biologics Ireland Limited Il-2 variants and fusion proteins thereof

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4615974A (en) 1981-08-25 1986-10-07 Celltech Limited Yeast expression vectors
US4579821A (en) 1981-11-23 1986-04-01 University Patents, Inc. Control of DNA sequence transcription
US4656134A (en) 1982-01-11 1987-04-07 Board Of Trustees Of Leland Stanford Jr. University Gene amplification in eukaryotic cells
US4486533A (en) 1982-09-02 1984-12-04 St. Louis University Filamentous fungi functional replicating extrachromosomal element
US4599311A (en) 1982-08-13 1986-07-08 Kawasaki Glenn H Glycolytic promotersfor regulated protein expression: protease inhibitor
US4977092A (en) 1985-06-26 1990-12-11 Amgen Expression of exogenous polypeptides and polypeptide products including hepatitis B surface antigen in yeast cells
US4601978A (en) 1982-11-24 1986-07-22 The Regents Of The University Of California Mammalian metallothionein promoter system
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
US5139936A (en) 1983-02-28 1992-08-18 Collaborative Research, Inc. Use of the GAL1 yeast promoter
US4661454A (en) 1983-02-28 1987-04-28 Collaborative Research, Inc. GAL1 yeast promoter linked to non galactokinase gene
US4650764A (en) 1983-04-12 1987-03-17 Wisconsin Alumni Research Foundation Helper cell
US4870008A (en) 1983-08-12 1989-09-26 Chiron Corporation Secretory expression in eukaryotes
US4931373A (en) 1984-05-25 1990-06-05 Zymogenetics, Inc. Stable DNA constructs for expression of α-1 antitrypsin
US4766073A (en) 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
EP0184576B1 (de) 1984-12-06 1990-06-27 Fina Research S.A. Promotoren für die Expression von fremden Genen in Hefe, Plasmide, die diese Promotoren enthalten, sowie deren Verwendung zur Herstellung von Polypeptiden
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
GR860984B (en) 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
US4882279A (en) 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
US4935349A (en) 1986-01-17 1990-06-19 Zymogenetics, Inc. Expression of higher eucaryotic genes in aspergillus
GB8611832D0 (en) 1986-05-15 1986-06-25 Holland I B Polypeptide
US4980289A (en) 1987-04-27 1990-12-25 Wisconsin Alumni Research Foundation Promoter deficient retroviral vector
US5063154A (en) 1987-06-24 1991-11-05 Whitehead Institute For Biomedical Research Pheromone - inducible yeast promoter
US5567584A (en) 1988-01-22 1996-10-22 Zymogenetics, Inc. Methods of using biologically active dimerized polypeptide fusions to detect PDGF
ATE140963T1 (de) 1988-01-22 1996-08-15 Zymogenetics Inc Verfahren zur herstellung von sekretierten rezeptoranalogen
US4956288A (en) 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
US5037743A (en) 1988-08-05 1991-08-06 Zymogenetics, Inc. BAR1 secretion signal
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5162228A (en) 1988-12-28 1992-11-10 Takeda Chemical Industries, Ltd. Gylceraldehyde-3-phosphate dehydrogenase gene and promoter
US5124263A (en) 1989-01-12 1992-06-23 Wisconsin Alumni Research Foundation Recombination resistant retroviral helper cell and products produced thereby
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5162222A (en) 1989-07-07 1992-11-10 Guarino Linda A Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
US5298418A (en) 1991-09-16 1994-03-29 Boyce Thompson Institute For Plant Research, Inc. Cell line isolated from larval midgut tissue of Trichoplusia ni
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
CA2144651A1 (en) 1992-09-14 1994-03-31 Timothy J. Miller Immortalized cells and uses therefor
WO1995007358A1 (en) 1993-07-30 1995-03-16 University Of Medicine & Dentistry Of New Jersey Efficient gene transfer into primary lymphocytes
RU2220979C2 (ru) * 1993-08-12 2004-01-10 Иммьюнекс Корпорейшн ПОЛИПЕПТИД ЛИГАНДА flt3 (ВАРИАНТЫ), ПОЛИНУКЛЕОТИД(ВАРИАНТЫ), ЭКСПРЕССИРУЮЩИЙ ВЕКТОР(ВАРИАНТЫ), ЛИНИЯ КЛЕТОК СНО (ВАРИАНТЫ), СПОСОБ ПРОДУЦИРОВАНИЯ ПОЛИПЕПТИДА ЛИГАНДА flt3 (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ (ВАРИАНТЫ)
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5795966A (en) * 1995-02-22 1998-08-18 Immunex Corp Antagonists of interleukin-15
AU1158297A (en) 1995-11-09 1997-05-29 Zymogenetics Inc. Production of gad65 in methylotrophic yeast
WO1998002565A1 (en) 1996-07-17 1998-01-22 Zymogenetics, Inc. TRANSFORMATION OF $i(PICHIA METHANOLICA)
IL128072A0 (en) 1996-07-17 1999-11-30 Zymogenetics Inc Preparation of pichia methanolica auxotrophic mutants
JP4215172B2 (ja) 1996-12-03 2009-01-28 アムジェン フレモント インク． 複数のＶ▲下Ｈ▼およびＶ▲下κ▼領域を含むヒトＩｇ遺伝子座を有するトランスジェニック哺乳動物、ならびにそれから産生される抗体
IL122818A0 (en) * 1997-07-10 1998-08-16 Yeda Res & Dev Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof
US6057128A (en) * 1998-03-17 2000-05-02 Genetics Institute, Inc. MU-1, member of the cytokine receptor family
MXPA01009074A (es) * 1999-03-09 2002-03-27 Zymogenetics Inc Nuevo ligando zalfa11 de citocina.
US9418201B1 (en) 2015-11-19 2016-08-16 International Business Machines Corporation Integration of functional analysis and common path pessimism removal in static timing analysis

Also Published As

Publication number Publication date
PL351160A1 (en) 2003-03-24
NZ514708A (en) 2005-01-28
EP1165791A2 (de) 2002-01-02
ES2295019T3 (es) 2008-04-16
JP4405686B2 (ja) 2010-01-27
CN1927883A (zh) 2007-03-14
DE60036930D1 (de) 2007-12-13
EP1165791B1 (de) 2007-10-31
CA2366921C (en) 2013-12-17
CZ20013184A3 (cs) 2002-04-17
CN102406937A (zh) 2012-04-11
NO20014364D0 (no) 2001-09-07
JP2002537839A (ja) 2002-11-12
HUP0200418A3 (en) 2003-12-29
RU2004126135A (ru) 2006-02-10
WO2000053761A2 (en) 2000-09-14
AU2005200240A1 (en) 2005-02-17
EP2295577A2 (de) 2011-03-16
NO20111085L (no) 2001-11-09
CN101575377B (zh) 2012-12-26
KR100743640B1 (ko) 2007-07-27
PL207350B1 (pl) 2010-12-31
CN101575377A (zh) 2009-11-11
IL145288A (en) 2010-11-30
BR0008772A (pt) 2002-05-07
IL207424A (en) 2013-04-30
ZA017370B (en) 2002-06-26
PT1165791E (pt) 2008-01-16
CN1927883B (zh) 2011-09-21
AU3731200A (en) 2000-09-28
IL195713A (en) 2010-11-30
EP1881070A3 (de) 2008-03-05
MXPA01009074A (es) 2002-03-27
KR20010103794A (ko) 2001-11-23
UA84387C2 (ru) 2008-10-27
EP1881070A2 (de) 2008-01-23
DE60036930T2 (de) 2008-10-09
EP1881070B1 (de) 2012-10-03
AU777842B2 (en) 2004-11-04
CN100500846C (zh) 2009-06-17
HU229148B1 (en) 2013-09-30
ATE377076T1 (de) 2007-11-15
CA2366921A1 (en) 2000-09-14
IL207403A (en) 2012-03-29
HUP0200418A2 (hu) 2002-05-29
NO20014364L (no) 2001-11-09
NO331551B1 (no) 2012-01-23
EP2295577A3 (de) 2012-08-08
CZ302921B6 (cs) 2012-01-18
RU2346951C2 (ru) 2009-02-20
WO2000053761A3 (en) 2000-12-21
CN1827639A (zh) 2006-09-06
BR0008772B1 (pt) 2011-11-01
CN1378595A (zh) 2002-11-06
DK1165791T3 (da) 2008-02-11

Similar Documents

Publication Publication Date Title
IL145288A0 (en) Novel cytokin zalpha11 ligand
EP1754789A3 (de) Bacillus-Stämme und Pestizid-Proteine
IL210454A0 (en) Novel cytokine zcytor17 ligand
IL133511A0 (en) Method for the preparation of citalopram
NZ514025A (en) Compositions and methods for the modification of gene transcription
DE3686217D1 (de) Alkalische protease, verfahren zur herstellung von hybridvektoren und genetisch transformierte mikroorganismen.
IL141869A0 (en) Mammalian transforming growth factor beta-9 (ztgfss9)
EP0967283A4 (de) Gene, die für proteine mit transglykolysierungsaktivität kodieren.
EP0751222A3 (de) Für Endoglycoceramidase kodierendes Gen
AU6710998A (en) Process for preparing modified proteins
PL348509A1 (en) Production of ascorbic acid using yeast
IL142709A0 (en) Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
CA2195975A1 (en) An improved process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides
EP0304971A3 (de) Verfahren zur Herstellung eines Polypeptids mit der Proteasehemmenden Aktivität von Säugetier-alpha-1-Antitrypsin
PL338215A1 (en) Method of obtaining 3-cyano-2,4-dichlorogeno-5-fluorobenzoic acids
DE69637429D1 (de) Gene, die für lymphocyte spezifischen interferon-regulationsfaktor (lsirf) polypeptide kodiert
DE69130259D1 (de) Neue DNA-Sequenz
EP1092773A3 (de) Polypeptid und dessen Verwendungen
EP1295943A4 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
TW197410B (de)
EP0359164A3 (de) Isolierung, Reinigung und Charakterisierung von Aminopeptidasen AP2, AP1 und APX
CA2240393A1 (en) Method for producing temperature-tolerant plants